A Study of the Drug Letermovir (LTV) as Prevention for Recurrent of Cytomegalovirus (CMV) Infection (clinicaltrials.gov) - Aug 11, 2025 - P2 | N=102 | Completed | Sponsor: Memorial Sloan Kettering Cancer Center | Active, not recruiting ➔ Completed
Trial completion • Bone Marrow Transplantation • Cytomegalovirus Infection • Infectious Disease • Transplantation
|